Home › NDC Lookup › RxCUI directory › RxCUI 758162

0.3 ML methoxy polyethylene glycol-epoetin beta 0.667 MG/ML Prefilled Syringe — RxCUI 758162

RxNorm drug concept · Semantic clinical drug
RxCUI 758162 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI758162
Official name0.3 ML methoxy polyethylene glycol-epoetin beta 0.667 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethoxy polyethylene glycol-epoetin beta 0.2 MG per 0.3 ML Prefilled Syringe; methoxy polyethylene glycol-epoetin beta 200 MCG in 0.3 ML Prefilled Syringe; methoxy polyethylene glycol-epoetin beta 200 MCG per 0.3 ML Prefilled Syringe
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)301,411 prescriptions · 39 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methoxy Polyethylene Glycol-Epoetin Beta Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Mircera isn't treating your kidneys directly — it's stepping in to do a job your kidneys can no longer do well. Healthy kidneys make a hormone called erythropoietin that tells your...
  • What exactly is Mircera doing for my kidneys?
  • That depends on your situation. If you're just starting treatment on dialysis, you'll likely receive Mircera every two weeks at first. Once your hemoglobin is stable, your doctor m...
  • How often will I need to get this injection?
📖 Read our full Methoxy Polyethylene Glycol-Epoetin Beta Injection guide →

🕸️ Concept Web — How 0.3 ML methoxy polyethylene glycol-epoetin beta... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.3 ML methoxy polyethylene glycol-epoetin beta 0.667 MG/ML Prefilled Syringe RxCUI 758162

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methoxy polyethylene glycol-epoetin beta 729596
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mircera 1591957
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methoxy polyethylene glycol-epoetin beta Prefilled Syringe 758158
    • Methoxy polyethylene glycol-epoetin beta Injectable Product 1162854
    • Methoxy polyethylene glycol-epoetin beta Prefilled Syringe [Mircera] 1591959
    • Mircera Injectable Product 1591960
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methoxy polyethylene glycol-epoetin beta 0.667 MG/ML SCDC · 758161
  • Methoxy polyethylene glycol-epoetin beta Prefilled Syringe SCDF · 758158
  • Methoxy polyethylene glycol-epoetin beta Injectable Product SCDG · 1162854

Brand-Name Concepts

📦 FDA Products & Package NDCs

9 products · 9 package NDCs
9 package NDCs map to RxCUI 758162 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59353-0400-09 1 SYRINGE, GLASS in 1 CARTON (59353-400-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0401-09 1 SYRINGE, GLASS in 1 CARTON (59353-401-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0402-09 1 SYRINGE, GLASS in 1 CARTON (59353-402-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0403-09 1 SYRINGE, GLASS in 1 CARTON (59353-403-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0404-09 1 SYRINGE, GLASS in 1 CARTON (59353-404-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0405-09 1 SYRINGE, GLASS in 1 CARTON (59353-405-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0406-09 1 SYRINGE, GLASS in 1 CARTON (59353-406-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0407-09 1 SYRINGE, GLASS in 1 CARTON (59353-407-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
59353-0408-09 1 SYRINGE, GLASS in 1 CARTON (59353-408-09) / 1 mL in 1 SYR... Mircera Vifor (International) Inc. 2014-10-24
Observed labelers: Vifor (International) Inc. (9) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0887 Epoetin beta esrd use 7 CMS
J0888 Epoetin beta non esrd 7 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.